Transcript
![Page 1: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/1.jpg)
Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD and Marc Passman, MD
![Page 2: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/2.jpg)
![Page 3: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/3.jpg)
![Page 4: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/4.jpg)
Low risk: 0-1 Moderate risk: 2 High risk: 3-4 Very high risk: >5
All are significant when compared with normal BMI
![Page 5: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/5.jpg)
![Page 6: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/6.jpg)
P<0.05 for all overweight categories compared with NW
![Page 7: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/7.jpg)
![Page 8: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/8.jpg)
![Page 9: Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD](https://reader035.vdocuments.us/reader035/viewer/2022062511/5513d2fa55034646298b51f1/html5/thumbnails/9.jpg)
Mean VTE scores increase with increasing BMI
Venous quality of life decreases with increasing BMI
VCSS and CEAP scoring increases with increasing BMI
Obesity contributes to CVD in the absence of moderate to severe valvular insufficiency